MDP on Improving Refractory Ankylosing Spondylitis Symptoms of Erythrocyte Sedimentation Rate and CRP

DOI

10.2991/icamcs-16.2016.2How to use a DOI?

Keywords

MDP, ankylosing spondylitis, erythrocyte sedimentation rate, CRP, clinical efficacy

Abstract

To explore the role of MDP to improve analysis of refractory ankylosing spondylitis symptoms of erythrocyte sedimentation rate and CRP. Methods: randomly selected in December 2013~December 2014 in our hospital 60 cases of patients with ankylosing spondylitis,and divided into control and experimental groups, each group 30 cases in which the control group with oral immunosuppressants way treatment,the experimental group increased MDP treatment based on immunosuppressants, following a month of treatment,observe the patient's ESR,CRP, total efficiency improvement and therapeutic effect. The experimental group after treatment,erythrocyte sedimentation rate,and other indicators to improve the value of CRP were significantly better than the control group,the total effective rate of 96.7% in the experimental group,the total effective rate was 76.7% in the control group,a statistically difference between two groups significance(P<0.05). MDP for refractory ankylosing inflammation treatment has a good clinical efficacy and fewer adverse reactions, significant efficacy, worthy of clinical application.

Copyright

© 2016, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Dan Guo
AU  - Ping Shuai
PY  - 2016/06
DA  - 2016/06
TI  - MDP on Improving Refractory Ankylosing Spondylitis Symptoms of Erythrocyte Sedimentation Rate and CRP
BT  - Proceedings of the 2016 5th International Conference on Advanced Materials and Computer Science
PB  - Atlantis Press
SP  - 5
EP  - 9
SN  - 2352-5401
UR  - https://doi.org/10.2991/icamcs-16.2016.2
DO  - 10.2991/icamcs-16.2016.2
ID  - Guo2016/06
ER  -